​​​​​​​​​​​​The Trusted Source for Preventive / Regenerative ​Medicine

​​​320 Santa Fe Drive, Suite 211

Encinitas, CA 92024



​​​​​​​​​California HealthSpan Institute      

Growth Hormone

Andreassen et al. Concentrations of the acute phase reactants high-sensitive C-reactive protein and YKL-40 and of interleukin-6 before and after treatment in patients with acromegalsy and growth hormone deficiency. Clin Edocrinol (Oxf). 2007 Aug 28

Bohdanowicz-Pawlek A et al. Risk factors of cardiovascular disease in GH-dificient adults with hypopituitarism: a preliminary report. Med Sci Monit. 2006 Feb;12(2):CR75-80

Bogarin R et al. Growth hormone treatment and risk of recurrence or progression of brain tumors in children: a review. Childs Nerv Syst. 2009 Jan 14

Branski LK et al. Randomized controlled trial to determine the efficacy of long-term growth hormone treatment in severely burned children . Ann Surg. 2009 Sep 2

Calao A et al. Beginning toend: Cardiovascular implications ofgrowth hormone (GH) deficiency and GH therapy. Growth Horm IGF Res.  2006 May 9

Collier SR et al. Growth hormone responses to varying doses of oral arginine. Horm IGF Res. 2005 Apr;15(2):136-9

Cuatrecasas G et al. Growth hormone as concomitant treatment in severe fibromyalgia associated with low IGF-1 serum levels. BMC Musculoskelet Disord. 2007 Nov 30

Franco C et al. Growth hormone treatment reduces abdominal visceral fat in postmenopausal women with abdominal obesity: a 12 month placebo controlled trial. J Clin Endocrinol Metab. 2005 Mar;90-93):1466-74

Ghigo E et al. Diagnosis of adult GH deficiency. Growth Horm IGF Res. 2008 Feb; 18(1):1-16

Ho KK et al. Regulating of growth hormone sensitivity by sex steroids: implications for therapy. Front Horm Res. 2006;35:115-28

Jenkins PJ et al. Does growth hormone cause cancer? Clin Endocrinol (Oxf). 2006 Feb;64(2):115-21

Johnsen P et al. Insulin-like growth factor (IGF) I,II and IGF Binding Protein-3 and risk of ischemic stroke. J Clin Endcrinol Metab 2005 90:5937-41

Major J et al. Insulin-like growth factor I and cancer mortality in older men. The J of Clin Endocrin & Metab.  2010 Mar;95(3):1054-9

Mitsi AC et al. Early, intracoronary growth hormone administration attenuates ventricular remodeling in a porcine model of myocardial infarction. Growth Horm IGF Res. 2006 Apr;16(2):93-100

Mitsi AC et al. Early selective growth hormone administration may ameliorate left ventricular remodeling after myocardial infarction. Med Hypotheses. 2005;64(3):582-5

Muniyappa R et al. Long-term testosterone supplementation augments overnight growth hormone secretion in health older men. Am J Physiol Endocrinol Metab. 2007

Popovic V et al. Hypopituitarism following traumatic brain injury. Growth Horm IGF Res. 2005 Jun;15(3):177-84

Sattler F et al. Testosterone threshold levels and lean tissue mass target needed to enhance skeletal muscle strength and function The HORMA Trial.  J Gerontol A Biol Sci Med Sci. 2010 Nov 8

Schernhammer ES et al. Insulin-like growth factor-I, its binding proteins (IGF-BP1 and IGF-BP3), and growth hormone and breast cancer risk in The Nurses Health Study II. Endocr Relat Cancer. 2006 Jun;13(2):583-92

Stockholm K et al. Mortality and GH deficiency: a nationwide study. Eur J of Endocrin. 2007;(157):9-18

Strassberger C et al.  How robust are laboratory measures of growth hormone status? Hormone Res 2005;(64):1-5

Thum T et al. Growth hormone treatment improves markers of systemic nitric oxide bioavalability via insulin-like growth factor I. J Clin Endocrinol Metab. 2007 Aug 28

Van Dam PS et al. Somatropin therapy and cognitive function in adults with growth hormone deficiency: a critical review. Treat Endocrinol. 2006;5(3):159-70